Cytomegalovirus Infection in Pregnancy: Prevention, Presentation, Management and Neonatal Outcomes
- PMID: 34031974
- DOI: 10.1111/jmwh.13228
Cytomegalovirus Infection in Pregnancy: Prevention, Presentation, Management and Neonatal Outcomes
Abstract
Congenital cytomegalovirus (cCMV) is the most common congenital infection in the United States, with 1 of 200 live births affected. It is the leading viral cause of intrauterine fetal demise and miscarriage. It is a common cause of neonatal hearing loss, second only to genetic factors. Yet, health care provider awareness remains low. The purpose of this article is to provide a brief overview of the epidemiology, presentation, diagnosis, and treatment of antenatal cytomegalovirus (CMV) infection and cCMV in the neonate. Maternal CMV infection in pregnancy often presents with mild cold-like symptoms or is asymptomatic. The virus can be vertically transmitted to a growing fetus, the risk of transmission and severity of fetal impact varying by timing of exposure during pregnancy. Most neonates born with cCMV show no signs at birth, yet 15% to 25% will have long-term adverse neurodevelopmental conditions. Misconceptions that cCMV cannot be prevented or that neonates born without signs of the disease will be unaffected are common. Evidence supporting antenatal education around behavioral change to lower a woman's risk of acquiring CMV during pregnancy is mounting. CMV infection during pregnancy should be co-managed with a maternal-fetal medicine specialist. There is early evidence for the use of antiviral medication in reducing risk of vertical transmission. Identification of cCMV during pregnancy may help ensure the neonate receives timely treatment after birth. Midwives can play an important role in providing antenatal education about cCMV risk reduction and in initiating a diagnostic evaluation when there is clinical suspicion.
Keywords: CMV; congenital cytomegalovirus; cytomegalovirus; fetal infection.
© 2021 by the American College of Nurse-Midwives.
Similar articles
-
Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.Arch Gynecol Obstet. 2020 Dec;302(6):1353-1359. doi: 10.1007/s00404-020-05728-7. Epub 2020 Aug 4. Arch Gynecol Obstet. 2020. PMID: 32754858 Free PMC article.
-
Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.J Infect Dis. 2020 Mar 5;221(Suppl 1):S15-S22. doi: 10.1093/infdis/jiz443. J Infect Dis. 2020. PMID: 32134482 Free PMC article.
-
Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):9-18. doi: 10.1111/ajo.12408. Epub 2015 Sep 22. Aust N Z J Obstet Gynaecol. 2016. PMID: 26391432 Review.
-
Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.J Matern Fetal Neonatal Med. 2019 Feb;32(4):617-625. doi: 10.1080/14767058.2017.1387890. Epub 2017 Oct 26. J Matern Fetal Neonatal Med. 2019. PMID: 28978246
-
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections.Curr Opin Infect Dis. 2024 Dec 1;37(6):494-505. doi: 10.1097/QCO.0000000000001067. Epub 2024 Oct 3. Curr Opin Infect Dis. 2024. PMID: 39417729 Review.
Cited by
-
Effect of Antimicrobial Exposure in Pregnancy on Adverse Pregnancy Outcomes and Admission Rate to the Neonatal Intensive Care Unit: A Multi-Center Cohort Study.Infect Drug Resist. 2023 Apr 25;16:2441-2451. doi: 10.2147/IDR.S392504. eCollection 2023. Infect Drug Resist. 2023. PMID: 37128496 Free PMC article.
-
An Overview of Cytomegalovirus Infection in Pregnancy.Diagnostics (Basel). 2022 Oct 7;12(10):2429. doi: 10.3390/diagnostics12102429. Diagnostics (Basel). 2022. PMID: 36292118 Free PMC article. Review.
-
Neurodevelopmental outcomes of children with congenital cytomegalovirus: a systematic scoping review.Pediatr Res. 2024 Jan;95(2):418-435. doi: 10.1038/s41390-023-02639-6. Epub 2023 May 24. Pediatr Res. 2024. PMID: 37225779 Free PMC article.
-
Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection.Viruses. 2023 Mar 23;15(4):819. doi: 10.3390/v15040819. Viruses. 2023. PMID: 37112800 Free PMC article. Review.
-
Congenital Cytomegalovirus-Related Hearing Loss.Audiol Res. 2024 Jun 16;14(3):507-517. doi: 10.3390/audiolres14030043. Audiol Res. 2024. PMID: 38920964 Free PMC article. Review.
References
REFERENCES
-
- Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57(suppl 4):S178-S181.
-
- Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clinical Microbiol Rev. 2013;26(1):86-102.
-
- Page JM, Bardsley T, Thorsten V, et al. Stillbirth associated with infection in a diverse U.S. cohort. Obstet Gynecol. 2019;134(6):1187-1196.
-
- Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188.
-
- Pesch MH, Anderson C, Mowers E. Improving obstetric provider congenital cytomegalovirus knowledge and practices. Infectious Dis Obstet Gynecol. 2020;2020:8875494.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical